MedTrace Logo

Registry of Acute Coronary Syndrome From University Hospital of Vigo

NCT03664388 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2018-09-10

No results posted yet for this study

Summary

CardoCHUVI registry was aim to study ischemic and bleeding complication after an acute coronary syndrome (ACS), both in-hospital and follow-up events.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Dual antiplatelet therapy with ticagrelor/prasuglre

Compare bleeding and ischemic events according to the type and duration of dual antiplatelet therapy

Sponsors & Collaborators

  • Hospital Álvaro Cunqueiro

    lead OTHER

Principal Investigators

  • Emad Abu-Assi, MD, PhD · University Hospital Álvaro Cunqueiro, Vigo, Spain

  • Sergio Raposeiras-Roubín, MD, PhD · University Hospital Álvaro Cunqueiro, Vigo, Spain

  • Andres Iñiguez-Romo, MD, PhD · University Hospital Álvaro Cunqueiro, Vigo, Spain

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2018-09-06
Completion
2020-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664388 on ClinicalTrials.gov